what percent of people regain weight after stopping glp 1 Many Patients Maintain Loss a Year Semaglutide and Liraglutide GLP-1 Survey: 37.5% of People

Stay tuned next week on 23rd December for the full 2026 Health Populi TrendCast with a focus on digital health trends we anticipate will set the stage for CES 2026

For patients on Ozempic experiencing hiccups, start with metoclopramide 10-20 mg orally or IV every 4-6 hours as first-line therapy, or alternatively use bac...

Organic rice hulls, hypromellose capsule

5, 2025), denying plaintiffs motion for (1) a preliminary injunction (PI) prohibiting the FDA from taking action against Outsourcing Facilities Association (OFA) members and FarmaKeio based on their compounding of the drug ingredient tirzepatide pending final judgment in the case and (2) a stay pending conclusion of the review proceedings in response to the FDAs declaration that the shortage of the diabetes and weight-loss tirzepatideproducts has been resolved.

Background Type 2 diabetes (T2D) is a leading cause of morbidity and mortality worldwide

When weight struggles are misread as laziness, shame compounds, motivation collapses, and the cycle tightens